AWM
STRO icon

Accredited Wealth Management’s Sutro Biopharma STRO Stock Holding History

Accredited Wealth Management’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$869 Sell
1
-99
-99% -$842 ﹤0.01% 356
2025
Q2 		$714 Hold
100
– – ﹤0.01% 356
2025
Q1 		$651 Buy
+100
New +$1.57K ﹤0.01% 343

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Accredited Wealth Management's STRO Position: Q3 2025 in Review

Accredited Wealth Management reduced its Sutro Biopharma (STRO) stake by 99% in Q3 2025, selling an estimated $842 and leaving 1 share worth $869. The position accounts for ﹤0.01% of the portfolio, ranked #356.

Accredited Wealth Management first reported a position in STRO in Q1 2025 and has held it in 3 quarters since. 87 funds tracked by Wall St. Rank hold STRO as of Q3 2025.

  • Accredited Wealth Management held 1 share of Sutro Biopharma worth $869 as of Q3 2025.
  • Accredited Wealth Management sold 99 Sutro Biopharma shares in Q3 2025, an estimated $842.
  • Sutro Biopharma made up ﹤0.01% of Accredited Wealth Management's portfolio in Q3 2025, its #356 holding.
  • Accredited Wealth Management first reported a position in Sutro Biopharma in Q1 2025 and has held it in 3 quarters since.
  • 87 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2025.

Based on Accredited Wealth Management's 13F filing for Q3 2025, filed 12 Nov 2025.